Company Announcements

Evotec and Sandoz Explore $300M Biologics Unit Sale in Toulouse: CDMO Capacity Shifts

Evotec has entered a non-binding agreement with Sandoz to explore the $300M sale of its Toulouse biologics facility, signaling shifts in CDMO…

March 27, 2026

Company Announcements

Evotec Refines 2025 Revenue Projections While Upholding Profit Targets: CDMO Market Implications

Evotec has revised its fiscal 2025 revenue forecast but left its R&D and adjusted EBITDA targets unchanged, a move with broad implications…

March 9, 2026

Company Announcements

Sharp’s SBTi-Validated Emission Goals: A New Benchmark for CDMO Sustainability

Sharp secures Science Based Targets initiative validation for its near- and long-term emissions reduction goals, reinforcing sustainable practices within CDMO pharmaceutical manufacturing…

March 9, 2026

Company Announcements

Northern RNA Strengthens Commercial Leadership with Appointment of Industry Veteran Todd Howren, PhD

Northern RNA has appointed Todd Howren, PhD, as Chief Commercial Officer to advance its CDMO services for RNA-based therapeutics and vaccines, bolstering…

March 9, 2026

Company Announcements

Generics Small Molecules: The CDMO Imperative in a Growing Market

As demand for generics small molecules rises, CDMOs must adapt through scalable capacity, rigorous regulatory compliance, and strategic partnerships to stay competitive.

March 8, 2026

Company Announcements

CDMOs Poised to Accelerate UF-KureX Solid Tumor Program After $400K NCI Grant

The NCI has awarded $400K to UF and KureX for solid tumor research, highlighting new CDMO collaboration opportunities in oncology biologics, manufacturing,…

March 8, 2026

Company Announcements

Sharp Services Expands Macungie Facility to Meet Growing Demand in Sterile Injectable CDMO Market

Sharp Services is investing in its Macungie, Pennsylvania facility to expand sterile injectable manufacturing capacity, aligning with growing CDMO outsourcing trends and…

December 27, 2025

Company Announcements

Kazia’s EVT801 Phase 1 Success: Implications for CDMO Partners in Oncology Manufacturing

Kazia’s EVT801 Phase 1 trial success highlights critical CDMO roles in scale-up, regulatory alignment, supply chain management and partnership models.

December 27, 2025

Company Announcements

Bayer and Evotec’s Precision Cardiology Collaboration: Implications for CDMOs

Bayer and Evotec’s renewed focus on precision cardiology drives new CDMO opportunities in manufacturing scale, regulatory alignment, supply chain resilience and advanced…

December 27, 2025

Company Announcements

Evotec Biologics Unveils J.CHO™ High Expression System: Impacts for CDMOs in Antibody Manufacturing

Evotec Biologics introduces the J.CHO™ High Expression System for continuous antibody production, offering CDMOs enhanced productivity, scalability and quality control.

December 27, 2025

Company Announcements

Evotec Appoints Dr Christian Wojczewski as CEO: Implications for the CDMO Sector

Evotec SE’s appointment of Dr Christian Wojczewski as CEO offers strategic direction for its CDMO services, impacting manufacturing capacity, outsourcing trends and…

December 26, 2025

Company Announcements

Evotec and Variant Bio Strategic Partnership: Implications for the CDMO Sector

Explore how the recent collaboration between Evotec and Variant Bio to develop fibrosis treatments creates opportunities and challenges for CDMOs in talent,…

December 26, 2025

Company Announcements

Evotec SE to Announce Fiscal Year 2023 Results: What the Pharma CDMO Sector Needs to Know

Evotec SE will release its 2023 financial results on April 24, 2024. CDMO stakeholders should assess the outcomes for insights on outsourcing…

December 25, 2025

Company Announcements

Evotec Appoints Aurélie Dalbiez as Chief People Officer: Strengthening CDMO Talent and Growth

Aurélie Dalbiez joins Evotec as Chief People Officer on June 15, 2024, to enhance talent strategies, workforce capacity and organizational culture across…

December 25, 2025

Company Announcements

Etherna Appoints Shelly West as US Business Development Director: Implications for CDMO Partnerships

Etherna expands its CDMO offerings in the US by appointing Shelly West as Business Development Director, driving mRNA partnerships and GMP manufacturing…

December 25, 2025

Company Announcements

Exothera Launches Continuous-Batch RNA Manufacturing Platform in North America to Boost CDMO Capabilities

Exothera has extended its world-first continuous-batch RNA manufacturing solution into North America, offering CDMOs automated, integrated production to accelerate clinical timelines, enhance…

December 25, 2025

Company Announcements

Breakpoint Therapeutics Nominates BTX-011 Development Candidate: CDMO Outsourcing Implications

Breakpoint Therapeutics' nomination of BTX-011 highlights critical CDMO opportunities in process development, manufacturing and regulatory support for DDR-targeting oncology drugs.

December 25, 2025

Company Announcements

Tubulis’ €128M Series B2 Raise Spurs CDMO Growth for ADC Development

Tubulis’ €128 million Series B2 financing will fuel its solid tumor ADC pipeline and drive increased CDMO engagement in capacity expansion, outsourcing,…

December 24, 2025

Company Announcements

Evotec and Claris Ventures Partnership to Streamline CDMO-Driven Clinical Acceleration

Evotec SE and Claris Ventures launch a framework to streamline portfolio biotech programmes through an integrated CDMO platform, boosting manufacturing efficiency, regulatory…

December 24, 2025

Company Announcements

Symbiosis Earns beMaster Plus Award and Its Implications for CDMO Exhibition Strategies

Symbiosis has been honored with the beMaster Plus award for build excellence in exhibition stand construction. This recognition offers key insights for…

December 24, 2025

Company Announcements

Leveraging CDMO Partnerships to Advance Anti-Infective Development Against Tuberculosis and Malaria

This article examines the partnership between Evotec and Helmholtz Institute, exploring how CDMOs facilitate the development, scale-up, and manufacturing of novel anti-infectives…

December 24, 2025

Company Announcements

etherna LNP Formulations: Implications for CDMO Manufacturing of mRNA Vaccines

A recent peer-reviewed paper from etherna demonstrates enhanced immune response and reduced reactogenicity of LNP-based mRNA vaccines, signaling new growth avenues for…

December 23, 2025

Company Announcements

Leveraging Standardized Viral Vector Platforms to Elevate CDMO Service

Explore how standardized viral vector platforms enable CDMOs to improve process efficiency, regulatory compliance, and capacity scalability in gene therapy production.

December 23, 2025

Company Announcements

Just – Evotec Biologics and ABL Deepen CDMO Partnership for HIV bnAb Development

Just – Evotec Biologics has deepened its development and manufacturing agreement with Advanced BioScience Laboratories (ABL), advancing CDMO capabilities for broadly neutralising…

December 23, 2025

Company Announcements

Sharp Services Commits to SBTi: CDMO Sustainability Strategies for Emissions Reduction

Sharp Services, a leader in pharmaceutical packaging and clinical trial supply, has joined the Science Based Targets initiative to drive greenhouse gas…

December 23, 2025

Company Announcements

Evotec SE Conference Call Signals Strategic Shifts in CDMO Landscape

Evotec SE’s upcoming conference call on January 22, 2024, will provide a business update with significant CDMO implications, covering outsourcing strategies, manufacturing…

December 23, 2025

Company Announcements

Modern Scalable Bioreactors: A CDMO Strategy for Gene and Cell Therapy Success

An in-depth examination of modern scalable bioreactor platforms and their strategic role in CDMO-driven gene and cell therapy manufacturing.

December 22, 2025

Company Announcements

Designing Stable Cell Line Strategies for Gene and Cell Therapy Manufacturing in a CDMO Environment

A detailed guide for CDMOs on designing robust stable cell line strategies for gene and cell therapy manufacturing, covering technical, regulatory, and…

December 22, 2025

Company Announcements

Evotec and Crohn’s & Colitis Foundation Partnership Drives CDMO Opportunities for IBD Therapies

Evotec’s alliance with the Crohn’s & Colitis Foundation signals intensified CDMO engagement in IBD drug development, highlighting opportunities in outsourcing, manufacturing scale-up,…

December 22, 2025

Company Announcements

Evotec-BMS Neuroscience Partnership: CDMO Implications

Evotec’s latest $25 million funding milestone with Bristol Myers Squibb highlights critical trends in neuroscience contract development and manufacturing, underscoring investment shifts,…

December 22, 2025

Company Announcements

Evotec and Owkin Forge AI-Driven Partnership: Implications for CDMO Services

Evotec and Owkin’s AI-integrated collaboration in oncology and I&I is poised to reshape CDMO outsourcing strategies, drive demand for advanced manufacturing services,…

December 21, 2025

Company Announcements

Evotec Announces CEO Transition: Implications for CDMO Strategies

Evotec's CEO transition prompts analysis of impacts on CDMO partnerships, manufacturing capacity and strategic outsourcing.

December 21, 2025

Company Announcements

Evotec Announces CEO Transition: Implications for CDMO Strategies

Evotec's CEO transition prompts analysis of impacts on CDMO partnerships, manufacturing capacity and strategic outsourcing.

December 21, 2025

Company Announcements

Evotec Announces CEO Transition: Implications for CDMO Strategies

Evotec's CEO transition prompts analysis of impacts on CDMO partnerships, manufacturing capacity and strategic outsourcing.

December 21, 2025

Company Announcements

Evotec CEO Transition: Implications for the CDMO Sector

Evotec’s CEO departure signals shifts in CDMO partnerships, capacity planning and outsourcing strategies, shaping the contract development landscape.

December 20, 2025

Company Announcements

Evotec Secures US$2.5M Gates Foundation Grant for iPSC-Based Teratogenicity Platform: CDMO Implications

Evotec has been awarded a US$2.5M grant by the Bill & Melinda Gates Foundation to support its human iPSC-derived teratogenicity testing platform,…

December 20, 2025

Company Announcements

Evotec and Charité Partnership: Implications for the CDMO Sector in Autoimmune Therapeutics

Evotec’s collaboration with Charité to develop a molecular database for ANCA-associated vasculitis reshapes CDMO approaches to data-driven development, outsourcing strategies, and manufacturing…

December 20, 2025

Company Announcements

Almirall and etherna’s mRNA Dermatology Alliance: Implications for CDMOs

A deep dive into how the Almirall-etherna mRNA dermatology collaboration influences CDMO capacity, technology transfer, regulatory and supply chain dynamics.

December 19, 2025

Company Announcements

Evotec Partner Jingxin Secures NMPA Approval for EVT201: Implications for CDMO Operations

Zhejiang Jingxin Pharma’s NMPA approval for EVT201 underscores emerging opportunities and challenges for CDMO providers in capacity planning, supply chain optimization, and…

December 19, 2025

Company Announcements

Evotec Expands beLAB1407 BRIDGE Partnership with BMS to Include Three UK Universities

Evotec SE has expanded its $20M beLAB1407 BRIDGE partnership with Bristol Myers Squibb to onboard the Universities of Bristol and Glasgow, and…

December 19, 2025

Company Announcements

Evotec’s Precision Medicine Platforms Signal New Opportunities for CDMOs

Evotec SE’s precision medicine platforms showcased at Capital Markets Day have major implications for CDMOs in areas from contract development to digital…

December 19, 2025

Company Announcements

Evotec SE Q3 2023 Results Reveal CDMO Sector Impact and Strategic Outlook

Evotec SE's nine-month 2023 financial results highlight key trends and strategies shaping the CDMO landscape, from capacity expansion to technological innovation.

December 19, 2025

Company Announcements

Evotec Secures SBTi Approval for Emissions Reduction Targets and Its Implications for CDMOs

Evotec’s recent approval from the Science Based Targets initiative for near term emissions goals underscores a growing sustainability focus within the CDMO…

December 18, 2025

Company Announcements

Evotec and Dewpoint Therapeutics Forge Strategic Oncology Partnership: CDMO Implications

Analysis of the Evotec-Dewpoint oncology partnership through a CDMO lens, highlighting development, manufacturing, outsourcing and regulatory impacts.

December 18, 2025

Company Announcements

Evotec SE to Announce Nine-Month 2023 Results: Implications for the CDMO Sector

Evotec SE’s upcoming nine-month 2023 financial report may signal shifts in the CDMO landscape. We explore its impact on contract development, manufacturing…

December 16, 2025

Company Announcements

How Sharp’s Acquisition of BSM Strengthens CDMO Sterile Manufacturing Capabilities

Explore the strategic impact of Sharp’s acquisition of Berkshire Sterile Manufacturing on sterile fill-finish capacity, regulatory synergies, and CDMO market dynamics.

November 23, 2025

Company Announcements

Evotec Joins iCARE4CVD Consortium to Shape CDMO Landscape in Cardiovascular R&D

Evotec’s entry into the international iCARE4CVD consortium underscores emerging opportunities for CDMOs in cardiovascular disease R&D, covering manufacturing scale-up, data analytics integration,…

November 23, 2025

Company Announcements

etherna Appoints Bernard Sagaert as CEO and Marijn Dekkers as Chairman: Implications for the CDMO Sector

Biotech firm etherna names Bernard Sagaert as CEO and Marijn Dekkers as Chairman, reshaping its CDMO partnership strategies, capacity planning, and regulatory…

November 23, 2025

Company Announcements

Evotec and Amplitude Ventures Partnership Signals New CDMO Strategies for Pre-Amp Innovation

Evotec SE and Amplitude Ventures have formed a BRIDGE partnership to launch Pre-Amp, a venture studio focusing on precision medicine. This article…

November 23, 2025

Company Announcements

Evotec Launches Cyprotex e-Store for ADME-Tox Ordering: Implications for CDMOs

Evotec’s Cyprotex e-Store simplifies ADME-Tox service ordering through an online portal, offering CDMOs enhanced transparency, efficiency, and regulatory support.

November 23, 2025

Company Announcements

Evotec and Partners Launch 65LAB to Strengthen CDMO Ecosystem in Singapore

Evotec and its partners launch 65LAB in Singapore to accelerate drug discovery and fortify CDMO collaboration and capacity across the Asia Pacific…

November 22, 2025

Company Announcements

Sharp Services Bolsters CDMO Sterile Manufacturing with Berkshire Acquisition

Sharp Services has acquired Berkshire Sterile Manufacturing, elevating its CDMO sterile fill-finish capabilities and reinforcing its U.S. pharmaceutical supply chain presence.

November 22, 2025

Company Announcements

Evotec Opens New State-of-the-Art Biology Facility on Dorothy Crowfoot Hodgkin Campus: CDMO Market Implications

Evotec’s new B95 facility on the Dorothy Crowfoot Hodgkin Campus represents a significant enhancement of its CDMO capabilities, offering expanded biologics development,…

November 22, 2025

Company Announcements

Evotec and LabCentral Alliance Enhances Early-Stage CDMO Capabilities

Evotec SE has formed a strategic partnership with LabCentral, BioLabs, and MBC BioLabs to bolster CDMO services and support early-stage biotech innovators…

November 22, 2025

Company Announcements

Evotec and LabCentral Alliance Enhances Early-Stage CDMO Capabilities

Evotec SE has formed a strategic partnership with LabCentral, BioLabs, and MBC BioLabs to bolster CDMO services and support early-stage biotech innovators…

November 22, 2025

Company Announcements

Evotec and Novo Nordisk Launch LAB eN² Accelerator: CDMO Perspectives

A detailed look at how Evotec and Novo Nordisk’s LAB eN² accelerator will shape CDMO operations, capacity and strategic outsourcing.

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec H1 2023 Results Highlight Growing CDMO Opportunities in Drug Development

Evotec SE’s first half 2023 report underscores rising demand for contract development and manufacturing services, driven by strategic partnerships, capacity investments, and…

November 21, 2025

Company Announcements

Evotec to Publish H1 2023 Results, Highlighting Strategic Impacts on the CDMO Sector

Evotec SE will release its first half-year 2023 earnings on August 29, 2023. This report will offer vital insights for contract development…

November 21, 2025

Company Announcements

Evotec–STORM Collaboration on STC-15: Implications for CDMO Partnerships

Evotec and STORM Therapeutics’ presentation of STC-15 at ACS Fall 2023 highlights CDMO collaboration trends, manufacturing demands, regulatory considerations, and outsourcing strategies.

November 21, 2025

Company Announcements

Symbiosis Marks 20 Years: A Milestone in CDMO Evolution

Symbiosis celebrates its 20th anniversary, reflecting on two decades of growth in the CDMO sector, technological innovation, regulatory alignment, and strategic partnerships…

November 21, 2025

Company Announcements

Evotec Adjusts 2023 Guidance After Cyber-Attack: Implications for CDMOs

Evotec has lowered its 2023 financial guidance after a cyber-attack disrupted operations, underscoring heightened cybersecurity and supply chain vulnerabilities in the CDMO…

November 20, 2025

Company Announcements

Steffen Helmling Joins Etherna as Chief Business Officer to Drive CDMO Expansion

Etherna appoints seasoned mRNA expert Steffen Helmling as Chief Business Officer to steer contract development and manufacturing growth across global CDMO operations.

November 20, 2025

Company Announcements

Mastering Project Coordination in CDMOs: Key Roles, Skills, and Impact on Pharma Manufacturing

Explore how a skilled Project Coordinator drives efficiency, compliance, and client satisfaction in contract development and manufacturing organizations (CDMOs).

November 20, 2025

Company Announcements

Hello CDMO World: Launching Our Insightful Pharma Manufacturing Dialogue

Explore our first in-depth CDMO industry blog post, addressing market trends, technological innovation, regulatory alignment, and collaboration strategies in pharmaceutical contract development.

November 20, 2025

Company Announcements

Onyx Scientific Limited Launches Industry-Focused Blog to Drive CDMO Engagement

Onyx Scientific Limited has published its inaugural blog post, signaling a strategic move to leverage content marketing, regulatory expertise, and digital engagement…

November 20, 2025